NEOG Neogen Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NEOG

Price (delayed)

$44.55

Market cap

$4.79B

P/E Ratio

78.16

Dividend/share

N/A

EPS

$0.57

Enterprise value

$4.71B

NEOGEN Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural ...

Highlights
Neogen's equity has increased by 16% YoY and by 4% QoQ
The revenue has grown by 12% YoY and by 4.1% from the previous quarter
NEOG's price to earnings (P/E) is 24% more than its 5-year quarterly average of 60.4 and 7% more than its last 4 quarters average of 70.0
The quick ratio is down by 8% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.neogen.com
Peers: PKI IDXX ILMN PACB

Key stats

What are the main financial stats of NEOG
Market
Shares outstanding
107.48M
Market cap
$4.79B
Enterprise value
$4.71B
Valuations
Price to earnings (P/E)
78.16
Price to book (P/B)
5.67
Price to sales (P/S)
10.13
EV/EBIT
62.61
EV/EBITDA
48.93
EV/Sales
10.06
Earnings
Revenue
$468.46M
EBIT
$75.27M
EBITDA
$96.31M
Free cash flow
$54.38M
Per share
EPS
$0.57
Free cash flow per share
$0.51
Book value per share
$7.85
Revenue per share
$4.4
TBVPS
$6.54
Balance sheet
Total assets
$920.19M
Total liabilities
$79.82M
Debt
$0
Equity
$840.38M
Working capital
$537.85M
Liquidity
Debt to equity
0
Current ratio
11.03
Quick ratio
8.82
Net debt/EBITDA
-0.78
Margins
EBITDA margin
20.6%
Gross margin
45.9%
Net margin
13%
Operating margin
15.8%
Efficiency
Return on assets
7%
Return on equity
7.7%
Return on invested capital
14.1%
Return on capital employed
8.7%
Return on sales
16.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NEOG stock price

How has the Neogen stock price performed over time
Intraday
4.55%
1 week
10.93%
1 month
1.83%
1 year
18.17%
YTD
12.36%
QTD
-3.24%

Financial performance

How have Neogen's revenue and profit performed over time
Revenue
$468.46M
Gross profit
$215.06M
Operating income
$74.17M
Net income
$60.88M
Gross margin
45.9%
Net margin
13%
The revenue has grown by 12% YoY and by 4.1% from the previous quarter
The gross profit is up by 10% YoY and by 2.9% from the previous quarter
The company's operating income rose by 10% YoY
The net margin is down by 8% year-on-year and by 5% since the previous quarter

Growth

What is Neogen's growth rate over time

Valuation

What is Neogen stock price valuation
P/E
78.16
P/B
5.67
P/S
10.13
EV/EBIT
62.61
EV/EBITDA
48.93
EV/Sales
10.06
NEOG's price to earnings (P/E) is 24% more than its 5-year quarterly average of 60.4 and 7% more than its last 4 quarters average of 70.0
The EPS is down by 3.4% since the previous quarter
Neogen's equity has increased by 16% YoY and by 4% QoQ
The P/B is 3% less than the 5-year quarterly average of 5.6
The price to sales (P/S) is 14% higher than the 5-year quarterly average of 8.5
The revenue has grown by 12% YoY and by 4.1% from the previous quarter

Efficiency

How efficient is Neogen business performance
The ROA is down by 10% year-on-year and by 5% since the previous quarter
Neogen's return on equity has decreased by 9% YoY and by 3.8% QoQ
The ROS is down by 7% year-on-year and by 5% since the previous quarter
The return on invested capital has declined by 6% year-on-year and by 4.1% since the previous quarter

Dividends

What is NEOG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NEOG.

Financial health

How did Neogen financials performed over time
The total assets has grown by 15% YoY and by 4.5% from the previous quarter
The total liabilities is up by 11% year-on-year and by 10% since the previous quarter
The debt is 100% smaller than the equity
Neogen's equity has increased by 16% YoY and by 4% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.